Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors
Clinical trial NCT03897283 · UNKNOWN
Trial details
- NCT number
- NCT03897283
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-20
- Primary completion
- 2020-06-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.